FOR IMMEDIATE RELEASE
MESA, Ariz. — July 16, 2023
The Marchand Institute for Minimally Invasive Surgery is excited to have published the largest study ever performed investigating the effects of COVID19 vaccinations in pregnancy. This study looked at the affect these vaccinations had on the health of both mother and baby, and how effective these vaccines were are preventing COVID19 infection in mothers and babies as well. The full paper is available online at the journal’s website at: https://www.nature.com/articles/s41541-023-00698-8, as well as available on the pubmed government site here: https://pubmed.ncbi.nlm.nih.gov/37454153/.
About the Marchand Institute for Minimally Invasive Surgery
The Marchand Institute for Minimally Invasive Surgery is a 501(c)(3) tax-exempt non-profit research and educational institution based in Mesa, Arizona (EIN 42-2857240). The Institute produces peer-reviewed systematic reviews and meta-analyses in minimally invasive gynecologic surgery and women’s health, conducts FDA clinical trials, and trains surgeons through an SLS-accredited fellowship. All reviews are prospectively registered with PROSPERO, reported to PRISMA standards and appraised using the Cochrane RoB 2 tool. The Institute accepts no pharmaceutical or medical device industry funding and declares no conflicts of interest. It is directed by Greg J. Marchand, MD, FACS, FACOG, FICS.
Media Contact
Maria A. Sainz, Director of Communications and Media Relations
Marchand Institute for Minimally Invasive Surgery
maria@marchandobgyn.com | (480) 999-0905
Interview requests, expert commentary topics, boilerplate and high-resolution images: Newsroom & Press Kit. Complete publication record with DOIs and PMIDs: Publications database. Methodology: How we run a review.
###